Cargando…
The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
INTRODUCTION: Type 2 diabetes mellitus (T2DM) progression often results in treatment intensification with injectable therapy to maintain glycemic control. Using pilot data from the Initiation of New Injectable Treatment Introduced after Anti-diabetic Therapy with Oral-only Regimens study, real-world...
Autores principales: | Thayer, Sarah, Wei, Wenhui, Buysman, Erin, Brekke, Lee, Crown, William, Grabner, Michael, Raparla, Swetha, Quimbo, Ralph, Cziraky, Mark J., Hu, Wenli, Cuddihy, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898354/ https://www.ncbi.nlm.nih.gov/pubmed/24293131 http://dx.doi.org/10.1007/s12325-013-0074-8 |
Ejemplares similares
-
A real‐world study of treatment patterns and outcomes in US managed‐care patients with type 2 Diabetes initiating injectable therapies
por: Wei, Wenhui, et al.
Publicado: (2017) -
The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
por: Palli, Swetha Rao, et al.
Publicado: (2015) -
Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study
por: Mody, Reema, et al.
Publicado: (2019) -
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol
por: Sethi, Sanjay, et al.
Publicado: (2023) -
The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus
por: Toth, Peter P, et al.
Publicado: (2012)